Evidence map›Paper›PMID 37036308›Full record

ArticleAnnals of medicine2023

Targeting GPC3

Dinuo Li, Yu Wang, Ce Shi, Shuai Fu, Yi-Fei Sun, Chen Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dinuo LiGastric Surgery Department, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Yu WangMolecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Ce ShiMolecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Shuai FuMolecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Yi-Fei SunMolecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Chen LiMolecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, JinZhou, Liaoning, China.
Jinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-associated fibroblasts (CAFs) are an important part of tumour microenvironment, but its role in immunotherapy of gastric cancer (GC) is still needed to further study. In this study, we firstly distinguish the GC related CAFs

Indexed as

Cancer-Associated FibroblastsStomach NeoplasmsGlypicansHumansProgrammed Cell Death 1 ReceptorTumor MicroenvironmentGlypicansGPC3 protein, humanProgrammed Cell Death 1 Receptorcancer-associated fibroblastsGastric cancerGPC3immunotherapysingle cell sequencing

Identifiers

PMID37036308
PMCPMC10088929
OpenAlexW4363646799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.